Current update on severe acute respiratory syndrome coronavirus 2 vaccine development with a special emphasis on gene therapy viral vector design and …
Severe acute respiratory syndrome (SARS) is a newly emerging infectious disease (COVID-
19) caused by the novel coronavirus SARS-coronavirus 2 (CoV-2). To combat the …
19) caused by the novel coronavirus SARS-coronavirus 2 (CoV-2). To combat the …
Insight into the Advances in Clinical Trials of SARS‐CoV‐2 Vaccines
SM Basheeruddin Asdaq, S Jomah… - Canadian Journal of …, 2022 - Wiley Online Library
Severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) has thrown a challenge to
the scientific community. Several interventions to stop or limit the spread of infection have …
the scientific community. Several interventions to stop or limit the spread of infection have …
New vaccine production platforms used in developing SARS-CoV-2 vaccine candidates
T Ura, A Yamashita, N Mizuki, K Okuda, M Shimada - Vaccine, 2021 - Elsevier
The threat of the current coronavirus disease pandemic, caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), is accelerating the development of potential …
syndrome coronavirus 2 (SARS-CoV-2), is accelerating the development of potential …
A systematic review of SARS-CoV-2 vaccine candidates
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an emerging virus that is
highly pathogenic and has caused the recent worldwide pandemic officially named …
highly pathogenic and has caused the recent worldwide pandemic officially named …
An outline of contributing vaccine technologies for SARS CoV2 advancing in clinical and preclinical phase-trials
SS Naz, I Munir - Recent patents on biotechnology, 2022 - ingentaconnect.com
Background: Severe Acute Respiratory Syndrome Coronavirus 2 (SARS CoV2) is an RNA
virus involving 4 structural and 16 non-structural proteins, and exhibiting high transmission …
virus involving 4 structural and 16 non-structural proteins, and exhibiting high transmission …
Recombinant vaccines for COVID-19
ABSTRACT SARS-CoV-2, the causative agent of COVID-19, has imposed a major public
health threat, which needs effective therapeutics and vaccination strategies. Several …
health threat, which needs effective therapeutics and vaccination strategies. Several …
Delving into revolutionary SARS-CoV-2 vaccine approaches: Molecular and virological examinations; principles of SARS-CoV-2 vaccine platform
F Edalat, FH Tabatabaie, A Moattari, A Letafati… - Vacunas (English …, 2024 - Elsevier
Abstract Coronavirus disease (COVID-19) is an infectious illness caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). It emerged in 2019 and quickly became …
respiratory syndrome coronavirus 2 (SARS-CoV-2). It emerged in 2019 and quickly became …
Efficacy of COVID-19 vaccines: From clinical trials to real life
D Deplanque, O Launay - Therapies, 2021 - Elsevier
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has rapidly spread around
the globe leading to the COVID-19 pandemic. To mitigate the effects of the virus on public …
the globe leading to the COVID-19 pandemic. To mitigate the effects of the virus on public …
Non-viral COVID-19 vaccine delivery systems
The novel corona virus termed severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) has spread throughout the globe at a formidable speed, causing tens of millions of …
CoV-2) has spread throughout the globe at a formidable speed, causing tens of millions of …
Development of SARS-CoV-2 vaccines: challenges, risks, and the way forward
VM Vashishtha, P Kumar - Human Vaccines & Immunotherapeutics, 2021 - Taylor & Francis
The COVID-19 pandemic mandates the development of a safe and effective Severe Acute
Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) vaccine. This review analyzes the …
Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) vaccine. This review analyzes the …